Company performance
Add to research
Current Price
as of Feb 13, 2025$76.00
P/E Ratio
10.90
Market Cap
$44.82B
Description
Add to research
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Metrics
Add to research
Overview
- HQIrvine, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerEW
- Price$76+0.24%
Trading Information
- Market cap$44.82B
- Float98.20%
- Average Daily Volume (1m)4,796,502
- Average Daily Volume (3m)4,877,871
- EPS$6.98
Company
- Revenue$5.44B
- Rev growth (1yr)-9.41%
- Net income$1.40B
- Gross margin79.54%
- EBITDA marginN/A
- EBITDAN/A
- EV$41.97B
- EV/Revenue7.72
- P/E10.90
- P/S8.37
- P/B4.70
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account
StreetAccount Metrics Recap - Edwards Lifesciences Q3 Earnings ($68.34, 0.00) (2023-10-25T20:22:05Z)
Factset